A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment - statnews.com

"I do think it's a revolution," said Paul Oberstein of NYU Langone's Perlmutter Cancer Center.

You are being redirected to the original discussion. Please continue if you want to read the full post.

Continue to original article

You will be redirected in 3 seconds.